Official reprint from UpToDate®
www.uptodate.com ©2015 UpToDate®

Epidemiology, etiology, and prevention of cerebral palsy

Geoffrey Miller, MD
Section Editors
Marc C Patterson, MD, FRACP
Carolyn Bridgemohan, MD
Deputy Editor
Carrie Armsby, MD, MPH


Cerebral palsy (CP) is a heterogeneous group of clinical syndromes that range in severity and are characterized by abnormal muscle tone, posture, and movement. These conditions are due to abnormalities of the developing brain resulting from a variety of causes. Although the disorder itself is not progressive, the clinical expression may change over time as the brain matures.

The epidemiology, etiology, and prevention of CP are reviewed here. The classification, clinical features, evaluation, diagnosis, management, and prognosis of CP are discussed separately:

(See "Clinical features and classification of cerebral palsy".)

(See "Evaluation and diagnosis of cerebral palsy".)

(See "Management and prognosis of cerebral palsy".)


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2015. | This topic last updated: Sep 3, 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2015 UpToDate, Inc.
  1. Oskoui M, Coutinho F, Dykeman J, et al. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol 2013; 55:509.
  2. Hirvonen M, Ojala R, Korhonen P, et al. Cerebral palsy among children born moderately and late preterm. Pediatrics 2014; 134:e1584.
  3. Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the "common" neurologic disorders? Neurology 2007; 68:326.
  4. Hjern A, Thorngren-Jerneck K. Perinatal complications and socio-economic differences in cerebral palsy in Sweden - a national cohort study. BMC Pediatr 2008; 8:49.
  5. Croen LA, Grether JK, Curry CJ, Nelson KB. Congenital abnormalities among children with cerebral palsy: More evidence for prenatal antecedents. J Pediatr 2001; 138:804.
  6. Pharoah PO, Cooke T, Rosenbloom L. Acquired cerebral palsy. Arch Dis Child 1989; 64:1013.
  7. Himmelmann K, Ahlin K, Jacobsson B, et al. Risk factors for cerebral palsy in children born at term. Acta Obstet Gynecol Scand 2011; 90:1070.
  8. Olegård R, Sabel KG, Aronsson M, et al. Effects on the child of alcohol abuse during pregnancy. Retrospective and prospective studies. Acta Paediatr Scand Suppl 1979; 275:112.
  9. O'Leary CM, Watson L, D'Antoine H, et al. Heavy maternal alcohol consumption and cerebral palsy in the offspring. Dev Med Child Neurol 2012; 54:224.
  10. Abel EL. Cerebral palsy and alcohol consumption during pregnancy: is there a connection? Alcohol Alcohol 2010; 45:592.
  11. Streja E, Miller JE, Bech BH, et al. Congenital cerebral palsy and prenatal exposure to self-reported maternal infections, fever, or smoking. Am J Obstet Gynecol 2013; 209:332.e1.
  12. Pharoah PO, Platt MJ, Cooke T. The changing epidemiology of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 1996; 75:F169.
  13. Platt MJ, Cans C, Johnson A, et al. Trends in cerebral palsy among infants of very low birthweight (<1500 g) or born prematurely (<32 weeks) in 16 European centres: a database study. Lancet 2007; 369:43.
  14. Robertson CM, Watt MJ, Yasui Y. Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years. JAMA 2007; 297:2733.
  15. Nelson KB. The epidemiology of cerebral palsy in term infants. Ment Retard Dev Disabil Res Rev 2002; 8:146.
  16. Nelson KB, Blair E. Prenatal Factors in Singletons with Cerebral Palsy Born at or near Term. N Engl J Med 2015; 373:946.
  17. Nelson KB. Can we prevent cerebral palsy? N Engl J Med 2003; 349:1765.
  18. Strijbis EM, Oudman I, van Essen P, MacLennan AH. Cerebral palsy and the application of the international criteria for acute intrapartum hypoxia. Obstet Gynecol 2006; 107:1357.
  19. Dykes FD, Dunbar B, Lazarra A, Ahmann PA. Posthemorrhagic hydrocephalus in high-risk preterm infants: natural history, management, and long-term outcome. J Pediatr 1989; 114:611.
  20. Perlman JM. Intrapartum hypoxic-ischemic cerebral injury and subsequent cerebral palsy: medicolegal issues. Pediatrics 1997; 99:851.
  21. Nelson KB. What proportion of cerebral palsy is related to birth asphyxia? J Pediatr 1988; 112:572.
  22. Hankins GD, Speer M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynecol 2003; 102:628.
  23. Ellenberg JH, Nelson KB. The association of cerebral palsy with birth asphyxia: a definitional quagmire. Dev Med Child Neurol 2013; 55:210.
  24. Executive summary: Neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists' Task Force on Neonatal Encephalopathy. Obstet Gynecol 2014; 123:896.
  25. Clancy RR, Sladky JT, Rorke LB. Hypoxic-ischemic spinal cord injury following perinatal asphyxia. Ann Neurol 1989; 25:185.
  26. Pharoah PO. Prevalence and pathogenesis of congenital anomalies in cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2007; 92:F489.
  27. Garne E, Dolk H, Krägeloh-Mann I, et al. Cerebral palsy and congenital malformations. Eur J Paediatr Neurol 2008; 12:82.
  28. Wu YW, Croen LA, Shah SJ, et al. Cerebral palsy in a term population: risk factors and neuroimaging findings. Pediatrics 2006; 118:690.
  29. Rankin J, Cans C, Garne E, et al. Congenital anomalies in children with cerebral palsy: a population-based record linkage study. Dev Med Child Neurol 2010; 52:345.
  30. Freeman JM, Nelson KB. Intrapartum asphyxia and cerebral palsy. Pediatrics 1988; 82:240.
  31. Brann AW. Factors during neonatal life that influence brain disorder. In: Prenatal and Perinatal Factors Associated with Brain Disorders (NIH Pub. No. 85-1149), Freeman JM (Ed), US Government Printing Office, Washington, DC 1998. p.263.
  32. Felix JF, Badawi N, Kurinczuk JJ, et al. Birth defects in children with newborn encephalopathy. Dev Med Child Neurol 2000; 42:803.
  33. Wood JW, Johnson KG, Omori Y. In utero exposure to the Hiroshima atomic bomb. An evaluation of head size and mental retardation: twenty years later. Pediatrics 1967; 39:385.
  34. Dekaban AS. Abnormalities in children exposed to x-radiation during various stages of gestation: tentative timetable of radiation injury to the human fetus. I. J Nucl Med 1968; 9:471.
  35. Brent RL, Beckman DA. Environmental teratogens. Bull N Y Acad Med 1990; 66:123.
  36. Rorke LB. A perspective: the role of disordered genetic control of neurogenesis in the pathogenesis of migration disorders. J Neuropathol Exp Neurol 1994; 53:105.
  37. Hilburger AC, Willis JK, Bouldin E, Henderson-Tilton A. Familial schizencephaly. Brain Dev 1993; 15:234.
  38. Haverkamp F, Zerres K, Ostertun B, et al. Familial schizencephaly: further delineation of a rare disorder. J Med Genet 1995; 32:242.
  39. Roessler E, Belloni E, Gaudenz K, et al. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 1996; 14:357.
  40. Dobyns WB, Andermann E, Andermann F, et al. X-linked malformations of neuronal migration. Neurology 1996; 47:331.
  41. Barkovich AJ, Kuzniecky RI, Dobyns WB, et al. A classification scheme for malformations of cortical development. Neuropediatrics 1996; 27:59.
  42. Dodge NN, Dobyns WB. Agenesis of the corpus callosum and Dandy-Walker malformation associated with hemimegalencephaly in the sebaceous nevus syndrome. Am J Med Genet 1995; 56:147.
  43. Ashwal S, Russman BS, Blasco PA, et al. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2004; 62:851.
  44. Schaefer GB. Genetics considerations in cerebral palsy. Semin Pediatr Neurol 2008; 15:21.
  45. Moreno-De-Luca A, Ledbetter DH, Martin CL. Genetic [corrected] insights into the causes and classification of [corrected] cerebral palsies. Lancet Neurol 2012; 11:283.
  46. MacLennan AH, Thompson SC, Gecz J. Cerebral palsy: causes, pathways, and the role of genetic variants. Am J Obstet Gynecol 2015.
  47. McMichael G, Bainbridge MN, Haan E, et al. Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Mol Psychiatry 2015; 20:176.
  48. Segel R, Ben-Pazi H, Zeligson S, et al. Copy number variations in cryptogenic cerebral palsy. Neurology 2015; 84:1660.
  49. Bundey S, Griffiths MI. Recurrence risks in families of children with symmetrical spasticity. Dev Med Child Neurol 1977; 19:179.
  50. Hemminki K, Sundquist K, Li X. Familial risks for main neurological diseases in siblings based on hospitalizations in Sweden. Twin Res Hum Genet 2006; 9:580.
  51. Tollånes MC, Wilcox AJ, Lie RT, Moster D. Familial risk of cerebral palsy: population based cohort study. BMJ 2014; 349:g4294.
  52. Kuroda MM, Weck ME, Sarwark JF, et al. Association of apolipoprotein E genotype and cerebral palsy in children. Pediatrics 2007; 119:306.
  53. Lien E, Andersen G, Bao Y, et al. Genes determining the severity of cerebral palsy: the role of single nucleotide polymorphisms on the amount and structure of apolipoprotein E. Acta Paediatr 2015; 104:701.
  54. Gibson CS, MacLennan AH, Hague WM, et al. Associations between inherited thrombophilias, gestational age, and cerebral palsy. Am J Obstet Gynecol 2005; 193:1437.
  55. O'Callaghan ME, Maclennan AH, Gibson CS, et al. Fetal and maternal candidate single nucleotide polymorphism associations with cerebral palsy: a case-control study. Pediatrics 2012; 129:e414.
  56. Gibson CS, MacLennan AH, Goldwater PN, et al. The association between inherited cytokine polymorphisms and cerebral palsy. Am J Obstet Gynecol 2006; 194:674.e1.
  57. Gibson CS, Maclennan AH, Dekker GA, et al. Candidate genes and cerebral palsy: a population-based study. Pediatrics 2008; 122:1079.
  58. Wells J, Rosenberg M, Hoffman G, et al. A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis. Pediatrics 2012; 129:e339.
  59. Petterson B, Nelson KB, Watson L, Stanley F. Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s. BMJ 1993; 307:1239.
  60. Pharoah PO, Cooke T. Cerebral palsy and multiple births. Arch Dis Child Fetal Neonatal Ed 1996; 75:F174.
  61. Larroche JC, Droullé P, Delezoide AL, et al. Brain damage in monozygous twins. Biol Neonate 1990; 57:261.
  62. Scheller JM, Nelson KB. Twinning and neurologic morbidity. Am J Dis Child 1992; 146:1110.
  63. Weig SG, Marshall PC, Abroms IF, Gauthier NS. Patterns of cerebral injury and clinical presentation in the vascular disruptive syndrome of monozygotic twins. Pediatr Neurol 1995; 13:279.
  64. Bonellie SR, Currie D, Chalmers J. Comparison of risk factors for cerebral palsy in twins and singletons. Dev Med Child Neurol 2005; 47:587.
  65. Bejar R, Vigliocco G, Gramajo H, et al. Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations. Am J Obstet Gynecol 1990; 162:1230.
  66. Pharoah PO. Twins and cerebral palsy. Acta Paediatr Suppl 2001; 90:6.
  67. Pharoah PO. Cerebral palsy in the surviving twin associated with infant death of the co-twin. Arch Dis Child Fetal Neonatal Ed 2001; 84:F111.
  68. Nelson KB. Prenatal origin of hemiparetic cerebral palsy: how often and why? Pediatrics 1991; 88:1059.
  69. Barmada MA, Moossy J, Shuman RM. Cerebral infarcts with arterial occlusion in neonates. Ann Neurol 1979; 6:495.
  70. Levy SR, Abroms IF, Marshall PC, Rosquete EE. Seizures and cerebral infarction in the full-term newborn. Ann Neurol 1985; 17:366.
  71. Wiklund LM, Uvebrant P. Hemiplegic cerebral palsy: correlation between CT morphology and clinical findings. Dev Med Child Neurol 1991; 33:512.
  72. Kuban KC, Leviton A. Cerebral palsy. N Engl J Med 1994; 330:188.
  73. Hanigan WC, Powell FC, Miller TC, Wright RM. Symptomatic intracranial hemorrhage in full-term infants. Childs Nerv Syst 1995; 11:698.
  74. Gradnitzer E, Urlesberger B, Maurer U, et al. [Cerebral hemorrhage in term newborn infants--an analysis of 10 years (1989-1999)]. Wien Med Wochenschr 2002; 152:9.
  75. Roland EH, Flodmark O, Hill A. Thalamic hemorrhage with intraventricular hemorrhage in the full-term newborn. Pediatrics 1990; 85:737.
  76. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997; 278:207.
  77. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. I. Univariate analysis of risks. Am J Dis Child 1985; 139:1031.
  78. Wu YW, Escobar GJ, Grether JK, et al. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 2003; 290:2677.
  79. Wu YW, Colford JM Jr. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA 2000; 284:1417.
  80. Wu YW. Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev 2002; 8:25.
  81. Ahlin K, Himmelmann K, Hagberg G, et al. Cerebral palsy and perinatal infection in children born at term. Obstet Gynecol 2013; 122:41.
  82. O'Shea TM. Cerebral palsy in very preterm infants: new epidemiological insights. Ment Retard Dev Disabil Res Rev 2002; 8:135.